# NURIX THERAPEUTICS INC (NRIX)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/NRIX/

- Reporting holders: 4
- Reported value: $128.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $95.2K | 4,014 | 0.0% | 6 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $30.1K | 1,270 | 0.0% | 12 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $1.7K | 72 | 0.0% | 4 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $1.4K | 61 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $128.4K |
| Q2 2026 | 215 | $3.0B |
| Q1 2026 | 195 | $1.8B |
| Q4 2025 | 182 | $2.2B |
| Q3 2025 | 172 | $792.3M |
| Q2 2025 | 165 | $1.0B |
| Q1 2025 | 170 | $1.0B |
| Q4 2024 | 176 | $1.5B |
| Q3 2024 | 172 | $1.5B |
| Q2 2024 | 173 | $1.4B |
| Q1 2024 | 140 | $797.1M |
| Q4 2023 | 131 | $509.0M |